Ko 143

• Supplier: R&D Systems
• Catalog: 3241
• Prices: $115.00, $249.00
• Sizes: 1 mg, 10 mg
• Cas Number: 461054-93-3
• Chemical Name: (3S,6S,12aS)-1,2,3,4,6,7,12,12a-Octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoicacid1,1-dimethylethylester
• Formula: C26H35N3O5
• Molecular Weight: 469.57
• Purity: >99%

Product References

Raltegravir permeability across blood-tissue barriers and the potential role of - Raltegravir permeability across blood-tissue barriers and the potential role of

Hoque MT, Kis O, De Rosa MF, Bendayan R. Antimicrob Agents Chemother. 2015 May;59(5):2572-82.

FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and - FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and

Westover D, Ling X, Lam H, Welch J, Jin C, Gongora C, Del Rio M, Wani M, Li F. Mol Cancer. 2015 Apr 28;14:92.

Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them - Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them

Moreno-Sanz G, Barrera B, Armirotti A, Bertozzi SM, Scarpelli R, Bandiera T, Prieto JG, Duranti A, Tarzia G, Merino G, Piomelli D. Pharmacol Res. 2014 Sep;87:87-93.

Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport - Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport

Hill CR, Jamieson D, Thomas HD, Brown CD, Boddy AV, Veal GJ. Biochem Pharmacol. 2013 Jan 1;85(1):29-37.

EZN-2208 (PEG-SN38) overcomes ABCG2-mediated topotecan resistance in - EZN-2208 (PEG-SN38) overcomes ABCG2-mediated topotecan resistance in

Zander SA, Sol W, Greenberger L, Zhang Y, van Tellingen O, Jonkers J, Borst P, Rottenberg S. PLoS One. 2012;7(9):e45248.

The transport of nifurtimox, an anti-trypanosomal drug, in an in vitro model of - The transport of nifurtimox, an anti-trypanosomal drug, in an in vitro model of

Watson CP, Dogruel M, Mihoreanu L, Begley DJ, Weksler BB, Couraud PO, Romero IA, Thomas SA. Brain Res. 2012 Feb 3;1436:111-21.

Erlotinib antagonizes ABC transporters in acute myeloid leukemia. - Erlotinib antagonizes ABC transporters in acute myeloid leukemia.

Lainey E, Sebert M, Thepot S, Scoazec M, Bouteloup C, Leroy C, De Botton S, Galluzzi L, Fenaux P, Kroemer G. Cell Cycle. 2012 Nov 1;11(21):4079-92.

The ABC membrane transporter ABCG2 prevents access of FAAH inhibitor URB937 to - The ABC membrane transporter ABCG2 prevents access of FAAH inhibitor URB937 to

Moreno-Sanz G, Barrera B, Guijarro A, d'Elia I, Otero JA, Alvarez AI, Bandiera T, Merino G, Piomelli D. Pharmacol Res. 2011 Oct;64(4):359-63.